Cargando…
Narasin inhibits tumor metastasis and growth of ERα-positive breast cancer cells by inactivation of the TGF-β/SMAD3 and IL-6/STAT3 signaling pathways
Treatment of human estrogen receptor (ER)-positive breast cancer (ER(+) BC) using conventional chemotherapy remains a challenge and is often ineffective as a result of tumor metastasis. The present study aimed to investigate the ability of narasin, an ionophore antibiotic, to potentially inhibit tum...
Autores principales: | Chen, Jing, Huang, Xieping, Li, Na, Liu, Boxia, Ma, Zhanbing, Ling, Jun, Yang, Wenjun, Li, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646975/ https://www.ncbi.nlm.nih.gov/pubmed/33174044 http://dx.doi.org/10.3892/mmr.2020.11624 |
Ejemplares similares
-
STAT3 selectively interacts with Smad3 to antagonize TGF-β signaling
por: Wang, Gaohang, et al.
Publicado: (2015) -
Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6/ STAT3 and TGF-β/SMAD3 signaling pathway
por: Wang, Wu-ping, et al.
Publicado: (2016) -
Safety and efficacy of Monteban(®) G100 (narasin) for chickens for fattening
por: Bampidis, Vasileios, et al.
Publicado: (2018) -
Safety and efficacy of Monteban(®) G100 (narasin) for ducks for fattening
por: Bampidis, Vasileios, et al.
Publicado: (2018) -
Oxidative stress induction by narasin augments doxorubicin’s efficacy in osteosarcoma
por: Han, Zhaoming, et al.
Publicado: (2023)